{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:50:29Z","timestamp":1790736629290,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2020678"],"award-info":[{"award-number":["BE2020678"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002703","name":"Jiangsu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lfs.2025.123966","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:36:22Z","timestamp":1757540182000},"page":"123966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Autophagy regulation in ovarian cancer chemoresistance: Molecular mechanisms and emerging frontiers"],"prefix":"10.1016","volume":"380","author":[{"given":"Yi-Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumeng","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Bao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0010","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.lfs.2025.123966_bb0015","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IGC.0000000000001118","article-title":"Ovarian cancer prevention, screening, and early detection","volume":"27","author":"Chien","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0020","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/auto.7.5.15066","article-title":"Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics","volume":"7","author":"O\u2019Donovan","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2025.123966_bb0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10555-018-9727-z","article-title":"Pro-survival autophagy and cancer cell resistance to therapy","volume":"37","author":"Das","year":"2018","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"10.1016\/j.lfs.2025.123966_bb0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4161\/auto.7.11.17661","article-title":"A comprehensive glossary of autophagy-related molecules and processes (2nd edition)","volume":"7","author":"Klionsky","year":"2011","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.lfs.2025.123966_bb0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.semcdb.2010.04.002","article-title":"Regulation of membrane biogenesis in autophagy via PI3P dynamics","volume":"21","author":"Noda","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0045","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jmb.2016.03.030","article-title":"Regulation of autophagy by signaling through the Atg1\/ULK1 complex","volume":"428","author":"Papinski","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1083\/jcb.201810099","article-title":"Autophagosome maturation: An epic journey from the ER to lysosomes","volume":"218","author":"Zhao","year":"2019","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084392","article-title":"HRES-1\/Rab4 promotes the formation of LC3(+) autophagosomes and the accumulation of mitochondria during autophagy","volume":"9","author":"Talaber","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2016.09.030","article-title":"p62 in Cancer: signaling adaptor beyond autophagy","volume":"167","author":"Moscat","year":"2016","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.lfs.2025.123966_bb0070","doi-asserted-by":"crossref","first-page":"15077","DOI":"10.1073\/pnas.2436255100","article-title":"Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor","volume":"100","author":"Yue","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6762","key":"10.1016\/j.lfs.2025.123966_bb0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2025.123966_bb0080","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1101\/gad.2016211","article-title":"Autophagy-deficient mice develop multiple liver tumors","volume":"25","author":"Takamura","year":"2011","journal-title":"Genes Dev."},{"issue":"15","key":"10.1016\/j.lfs.2025.123966_bb0085","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1101\/gad.283416.116","article-title":"Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells","volume":"30","author":"Guo","year":"2016","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1101\/gad.2016311","article-title":"Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis","volume":"25","author":"Guo","year":"2011","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14715\/cmb\/2017.63.4.11","article-title":"The emerging role of oxidative stress in regulating autophagy: applications of cancer therapy","volume":"63","author":"Zhang","year":"2017","journal-title":"Cell. Mol. Biol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41388-017-0046-6","article-title":"Dual role of autophagy in hallmarks of cancer","volume":"37","author":"Singh","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1267\/ahc.14048","article-title":"High expression of SQSTM1\/p62 protein is associated with poor prognosis in epithelial ovarian cancer","volume":"47","author":"Iwadate","year":"2014","journal-title":"Acta Histochem. Cytochem."},{"issue":"8","key":"10.1016\/j.lfs.2025.123966_bb0115","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4161\/auto.6827","article-title":"Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer","volume":"4","author":"Shen","year":"2008","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.humpath.2014.02.008","article-title":"Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma","volume":"45","author":"Dai","year":"2014","journal-title":"Hum. Pathol."},{"issue":"22","key":"10.1016\/j.lfs.2025.123966_bb0125","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1158\/0008-5472.CAN-08-2592","article-title":"PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival","volume":"68","author":"Bartholomeusz","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0130","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e33","article-title":"Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas","volume":"28","author":"Miyamoto","year":"2017","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0135","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1186\/s12885-022-10248-5","article-title":"HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K\/AKT\/mTOR and p38 MAPK signaling pathways","volume":"22","author":"Nie","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2025.123966_bb0140","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.12659\/MSM.915730","article-title":"Knockdown of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) promotes autophagy and inhibits phosphatidylinositol 3-kinase (PI3K)\/AKT\/mammalian target of rapamycin (mTOR) signaling pathway in ovarian cancer cells","volume":"25","author":"Huang","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.lfs.2025.123966_bb0145","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/cdd.2014.48","article-title":"ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras\/MAP signaling and activating the FOXo3a-mediated induction of Rab7","volume":"21","author":"Lu","year":"2014","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0150","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8020","article-title":"Triptolide inhibits JAK2\/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin-resistant SKOV3\/DDP ovarian cancer cells","volume":"45","author":"Zhong","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2025.123966_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3145182","article-title":"Apatinib, a novel tyrosine kinase inhibitor, promotes ROS-dependent apoptosis and autophagy via the Nrf2\/HO-1 pathway in ovarian cancer cells","volume":"2020","author":"Sun","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/mmr.2014.2671","article-title":"Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells","volume":"11","author":"Bao","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/15548627.2015.1009781","article-title":"Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy","volume":"11","author":"He","year":"2015","journal-title":"Autophagy"},{"issue":"16","key":"10.1016\/j.lfs.2025.123966_bb0170","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1242\/jcs.081232","article-title":"p62\/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate","volume":"124","author":"Watanabe","year":"2011","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.lfs.2025.123966_bb0175","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1074\/mcp.M116.058321","article-title":"Hyper-phosphorylation of Sequestosome-1 distinguishes resistance to cisplatin in patient derived high grade serous ovarian cancer cells","volume":"16","author":"Nguyen","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"21","key":"10.1016\/j.lfs.2025.123966_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213509","article-title":"Integration of O-GlcNAc into stress response pathways","volume":"11","author":"Fahie","year":"2022","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.lfs.2025.123966_bb0185","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.7150\/thno.27806","article-title":"Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"issue":"9\u201310","key":"10.1016\/j.lfs.2025.123966_bb0190","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10495-022-01762-9","article-title":"Ambra1 in cancer: implications for clinical oncology","volume":"27","author":"Qin","year":"2022","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2131\/jts.41.45","article-title":"shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin","volume":"41","author":"Li","year":"2016","journal-title":"J. Toxicol. Sci."},{"issue":"15","key":"10.1016\/j.lfs.2025.123966_bb0200","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1158\/1078-0432.CCR-13-0495","article-title":"HMGB1 in cancer: good, bad, or both?","volume":"19","author":"Kang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123966_bb0205","first-page":"4586","article-title":"Downregulation of high mobility group protein box-1 resensitizes ovarian cancer cells to carboplatin","author":"Shu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.lfs.2025.123966_bb0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/onc.2011.290","article-title":"NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response","volume":"31","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.lfs.2025.123966_bb0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0220","first-page":"533","article-title":"HIF-1\u03b1-induced autophagy contributes to cisplatin resistance in ovarian cancer cells","volume":"73","author":"Long","year":"2018","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0230","first-page":"1491","article-title":"Cervical carcinoma high-expressed long non-coding RNA 1 may promote growth of colon adenocarcinoma through interleukin-17A","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2025.123966_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-018-3483-9","article-title":"IL-17A\/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer","volume":"455","author":"Wu","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0240","first-page":"9647","article-title":"Activation of the TLR4\/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A","volume":"15","author":"Kang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0245","first-page":"5475","article-title":"Association of serum interleukin-10, interleukin-17A and transforming growth factor-\u03b1 levels with human benign and malignant breast diseases","volume":"15","author":"Lv","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.lfs.2025.123966_bb0250","first-page":"1550","article-title":"IL-17A\/lL-17RA reduces cisplatin sensitivity of ovarian cancer SKOV3 cells by regulating autophagy","volume":"40","author":"Wang","year":"2020","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0255","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2025.123966_bb0260","doi-asserted-by":"crossref","DOI":"10.3727\/096504017X15138991620238","article-title":"MiRNA-409-3p enhances cisplatin-sensitivity of ovarian cancer cells by blocking the autophagy mediated by Fip200","author":"Cheng","year":"2018","journal-title":"Oncol. Res."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0265","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/jpm13091302","article-title":"miR-429 suppresses endometrial cancer progression and drug resistance via DDX53","volume":"13","author":"Lee","year":"2023","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0270","first-page":"1357","article-title":"Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1","volume":"9","author":"Zou","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2014.09.012","article-title":"MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr\u00fcppel-like factor 4","volume":"355","author":"Ma","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0280","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4161\/cbt.27630","article-title":"MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines","volume":"15","author":"Azizi","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2025.123966_bb0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/OTT.S485100","article-title":"Mechanism of microRNA-152-3p-mediated regulation of autophagy and sensitivity in paclitaxel-resistant ovarian cancer cells","volume":"18","author":"Wu","year":"2025","journal-title":"Onco. Targets. Ther."},{"issue":"13","key":"10.1016\/j.lfs.2025.123966_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-based diagnosis and therapy","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0295","first-page":"90","article-title":"Omeprazole enhances cisplatin sensitivity through inhibition of miR-214-3p mediated autophagy in epithelial ovarian cancer cells","volume":"53","author":"Cai","year":"2024","journal-title":"Acta Med. Univ. Sci. Technol. Huazhong"},{"issue":"15","key":"10.1016\/j.lfs.2025.123966_bb0300","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.lfs.2025.123966_bb0305","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1158\/0008-5472.CAN-11-1021","article-title":"Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers","volume":"71","author":"Kogo","year":"2011","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0310","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1177\/147323001103900608","article-title":"Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression","volume":"39","author":"Geng","year":"2011","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0315","first-page":"911","article-title":"High expression level of long non-coding RNA HOTAIR is associated with poor overall survival in gastric cancer patients: evidence from meta-analysis","volume":"22","author":"Da","year":"2017","journal-title":"J. B.U.ON."},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0320","first-page":"1396","article-title":"Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy","volume":"23","author":"Yu","year":"2018","journal-title":"J. B.U.ON."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0325","first-page":"928","article-title":"Cisplatin suppresses tumor proliferation by inhibiting autophagy in ovarian cancer via long non-coding RNA RP11-135L22.1","volume":"22","author":"Zou","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2025.123966_bb0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cca.2018.01.005","article-title":"Prognostic and clinicopathological value of long noncoding RNA XIST in cancer","volume":"479","author":"Zhu","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0335","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e81","article-title":"LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p\/FOXP1 axis","volume":"33","author":"Xia","year":"2022","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2015.11.040","article-title":"A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells","volume":"371","author":"Jhaveri","year":"2016","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0345","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1535-7163.MCT-13-0882","article-title":"A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo","volume":"13","author":"Chen","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0350","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13046-019-1249-1","article-title":"NEO212 induces mitochondrial apoptosis and impairs autophagy flux in ovarian cancer","volume":"38","author":"Song","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2025.123966_bb0355","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.4103\/0973-1482.235340","article-title":"Triptolide: a new star for treating human malignancies","volume":"14","author":"Yan","year":"2018","journal-title":"J. Cancer Res. Ther."},{"issue":"13","key":"10.1016\/j.lfs.2025.123966_bb0360","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0365","first-page":"1502","article-title":"Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma","volume":"7","author":"Bao","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123966_bb0370","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"21","key":"10.1016\/j.lfs.2025.123966_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112893","article-title":"Metformin improves ovarian cancer sensitivity to paclitaxel and platinum-based drugs: a review of in vitro findings","volume":"23","author":"Tossetta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0380","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2004-822993","article-title":"Low-density lipoprotein receptor--its structure, function, and mutations","volume":"4","author":"Defesche","year":"2004","journal-title":"Semin. Vasc. Med."},{"issue":"8","key":"10.1016\/j.lfs.2025.123966_bb0385","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/kjm2.12696","article-title":"LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K\/AKT\/mTOR signaling pathway","volume":"39","author":"Liu","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2025.123966_bb0390","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/onc.2016.281","article-title":"UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy","volume":"36","author":"Hu","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0395","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2017.09.091","article-title":"UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53","volume":"493","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0400","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13048-023-01314-y","article-title":"Activation of PI3K\/AKT\/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.lfs.2025.123966_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5167829","article-title":"MiR-30a: a novel biomarker and potential therapeutic target for cancer","volume":"2018","author":"Jiang","year":"2018","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0410","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1080\/21655979.2021.2001989","article-title":"Microrna miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy","volume":"12","author":"Cai","year":"2021","journal-title":"Bioengineered"},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0415","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.freeradbiomed.2009.07.021","article-title":"Thioredoxin-related protein 14, a new member of the thioredoxin family with disulfide reductase activity: implication in the redox regulation of TNF-alpha signaling","volume":"47","author":"Jeong","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0420","first-page":"1343","article-title":"TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer","volume":"42","author":"Tan","year":"2019","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2025.123966_bb0425","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1007\/s00210-024-03672-w","article-title":"Therapeutic role of naringin in cancer: molecular pathways, synergy with other agents, and nanocarrier innovations","volume":"398","author":"Alhalmi","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123966_bb0430","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.21037\/tcr-23-2156","article-title":"Naringin inhibits cisplatin resistance of ovarian cancer cells by inhibiting autophagy mediated by the TGF-\u03b22\/smad2 pathway","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.lfs.2025.123966_bb0435","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2017.05.013","article-title":"Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach","volume":"179","author":"Presta","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2025.123966_bb0440","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4614-0887-1_12","article-title":"FGF19 and cancer","volume":"728","author":"Lin","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2025.123966_bb0445","article-title":"FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer","volume":"11","author":"Zhu","year":"2023","journal-title":"PeerJ"},{"issue":"31","key":"10.1016\/j.lfs.2025.123966_bb0450","doi-asserted-by":"crossref","first-page":"31104","DOI":"10.18632\/oncotarget.5093","article-title":"A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer","volume":"6","author":"Delaney","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lfs.2025.123966_bb0455","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2017.12.013","article-title":"A phase II study of apatinib in patients with recurrent epithelial ovarian cancer","volume":"148","author":"Miao","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0460","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(18)30349-8","article-title":"Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study","volume":"19","author":"Lan","year":"2018","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123966_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050903","article-title":"188Re-liposome can induce mitochondrial autophagy and reverse drug resistance for ovarian cancer: from bench evidence to preliminary clinical proof-of-concept","volume":"18","author":"Chang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.123966_bb0470","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41419-022-04508-2","article-title":"Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer","volume":"13","author":"Bi","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0475","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1541-7786.MCR-23-0680","article-title":"Crizotinib enhances PARP inhibitor efficacy in ovarian cancer cells and xenograft models by inducing autophagy","volume":"22","author":"Santiago-O\u2019Farrill","year":"2024","journal-title":"Mol. Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2025.123966_bb0480","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12032-023-02138-y","article-title":"Cancer chemoresistance and its mechanisms: associated molecular factors and its regulatory role","volume":"40","author":"Kannampuzha","year":"2023","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.lfs.2025.123966_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.327","article-title":"Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells","volume":"8","author":"Pagotto","year":"2017","journal-title":"Cell Death Dis."},{"issue":"50","key":"10.1016\/j.lfs.2025.123966_bb0490","doi-asserted-by":"crossref","first-page":"83476","DOI":"10.18632\/oncotarget.13080","article-title":"Autophagy as an emerging therapy target for ovarian carcinoma","volume":"7","author":"Zhan","year":"2016","journal-title":"Oncotarget"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:17:05Z","timestamp":1770916625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525006022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":98,"alternative-id":["S0024320525006022"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123966","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy regulation in ovarian cancer chemoresistance: Molecular mechanisms and emerging frontiers","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123966"}}